Skip to content
Therapy But Better – Lifestyle
Author:
BioVie, Inc.
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
May 18, 2026
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26, on May 7, 2026
April 27, 2026
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
April 14, 2026
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
March 12, 2026